Clinical Trials Browser

Phase 2 × Genetic Diseases, Inborn × Genitourinary × Clear all

NCT00019695 2024-03-04

Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer

Phase 2 Terminated

Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms, Genetic Diseases, Inborn

NCT00020046 2023-10-31

Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer

Phase 2 Completed

Neoplasms, Prostatic Neoplasms, Genetic Diseases, Inborn